Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

YTEN

Yield10 Bioscience Inc

Apr 26 • 04:00PM ET

0.2218

Dollar change -0.0172
Percentage change -7.20	%

Basic Materials • Agricultural Inputs • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF CCSO

Index	-	P/E	-	EPS (ttm)	-2.08	Insider Own	19.42%	Shs Outstand	15.40M	Perf Week	-13.02%
Market Cap	3.42M	Forward P/E	-	EPS next Y	-0.85	Insider Trans	-2.32%	Shs Float	12.41M	Perf Month	-40.87%
Income	-14.46M	PEG	-	EPS next Q	-0.11	Inst Own	3.94%	Short Float	1.76%	Perf Quarter	1.37%
Sales	0.06M	P/S	56.93	EPS this Y	58.52%	Inst Trans	-3.79%	Short Ratio	0.04	Perf Half Y	-37.17%
Book/sh	-0.21	P/B	-	EPS next Y	-12.58%	ROA	-241.08%	Short Interest	0.22M	Perf Year	-92.35%
Cash/sh	0.07	P/C	3.19	EPS next 5Y	0.00%	ROE	-1508.09%	52W Range	0.18 - 3.29	Perf YTD	-7.31%
Dividend Est.	-	P/FCF	-	EPS past 5Y	45.25%	ROI	-	52W High	-93.26%	Beta	1.69
Dividend TTM	-	Quick Ratio	0.29	Sales past 5Y	-18.49%	Gross Margin	-566.67%	52W Low	23.22%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	0.29	EPS Y/Y TTM	24.47%	Oper. Margin	-24028.33%	RSI (14)	38.05	Volatility	14.98% 20.69%
Employees	29	Debt/Eq	-	Sales Y/Y TTM	-86.67%	Profit Margin	-24091.67%	Recom	3.00	Target Price	0.50
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	59.38%	Payout	-	Rel Volume	0.06	Prev Close	0.24
Sales Surprise	-	EPS Surprise	11.48%	Sales Q/Q	-100.00%	Earnings	Apr 01 AMC	Avg Volume	5.06M	Price	0.22
SMA20	-27.61%	SMA50	-23.32%	SMA200	-52.41%	Trades		Volume	326,796	Change	-7.20%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-08-24	Downgrade	Lake Street	Buy → Hold
Sep-10-20	Initiated	H.C. Wainwright	Buy	$25
Aug-27-20	Upgrade	National Securities	Neutral → Buy	$15
Nov-18-19	Downgrade	National Securities	Buy → Neutral
May-31-19	Resumed	Maxim Group	Buy
Jul-12-18	Initiated	Maxim Group	Buy	$7

Apr-05-24 08:53AM	Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcript (Insider Monkey) +5.77%
Apr-02-24 06:34AM	Q4 2023 Yield10 Bioscience Inc Earnings Call (Thomson Reuters StreetEvents) -42.57%
Apr-01-24 08:53PM	YTEN Stock Earnings: Yield10 Bioscience Beats EPS for Q4 2023 (InvestorPlace)
04:01PM	Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-28-24 04:01PM	Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 (GlobeNewswire)
08:29AM	Loading…
Mar-26-24 08:29AM	Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada (GlobeNewswire)
Mar-21-24 11:05AM	Why Is Yield10 (YTEN) Stock Up 117% Today? (InvestorPlace) +78.85%
08:29AM	USDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United States (GlobeNewswire)
Feb-29-24 08:31AM	Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests (GlobeNewswire) -7.25%
Feb-14-24 09:00AM	Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock (GlobeNewswire) +6.46%
Feb-07-24 05:40PM	Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program (GlobeNewswire)
Feb-05-24 07:47AM	Why Is Yield10 Bioscience (YTEN) Stock Up 34% Today? (InvestorPlace) +52.57%
Jan-08-24 08:31AM	Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil (GlobeNewswire)
Nov-16-23 09:12AM	Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-15-23 08:32AM	USDA-APHIS Determines that Yield10 Bioscience's Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States (GlobeNewswire) -15.33%
08:31AM	Loading…
08:31AM	USDA-APHIS Determines that Yield10 Bioscience's Glufosinate Tolerant Camelina May Be Planted and Bred in the United States (GlobeNewswire)
Nov-14-23 04:01PM	Yield10 Bioscience Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-08-23 08:31AM	Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023 (GlobeNewswire) -10.71%
Oct-31-23 08:31AM	Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land (GlobeNewswire)
Oct-18-23 08:31AM	Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research (GlobeNewswire) +15.27%
Oct-11-23 08:31AM	Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina (GlobeNewswire) +15.19%
Oct-03-23 08:31AM	Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production (GlobeNewswire)
Sep-07-23 08:31AM	Yield10 Bioscience to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-15-23 01:00PM	Yield10 Bioscience Announces Closing of $3.7 Million Public Offering (GlobeNewswire)
11:08AM	Q2 2023 Yield10 Bioscience Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 04:01PM	Yield10 Bioscience Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-13-23 10:00AM	Insider Purchases Worth US$1.0m See Losses As Yield10 Bioscience Market Value Drops To US$5.3m (Simply Wall St.)
Aug-11-23 09:15AM	Yield10 Bioscience to Announce Second Quarter 2023 Financial Results and Host a Conference Call on Monday, August 14, 2023 (GlobeNewswire) -55.45%
08:30AM	Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering (GlobeNewswire)
Aug-02-23 08:35AM	Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market (GlobeNewswire) -10.57%
08:40AM	Loading…
Jul-26-23 08:40AM	Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHISs SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil (GlobeNewswire) +7.61%
May-10-23 04:02PM	Yield10 Bioscience Announces First Quarter 2023 Financial Results (GlobeNewswire) +6.69%
May-04-23 08:31AM	Yield10 Bioscience to Announce First Quarter 2023 Financial Results and Host a Conference Call on Wednesday, May 10, 2023 (GlobeNewswire)
May-03-23 09:40AM	Yield10 Bioscience Announces Pricing of $3.0 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
May-01-23 09:17AM	Yield10 Bioscience and Marathon Petroleum Corporation Sign LOI for Potential Investment and Offtake Agreement for Camelina Feedstock Oil for Renewable Fuels (GlobeNewswire)
Mar-17-23 04:56AM	Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-15-23 09:19AM	Q4 2022 Yield10 Bioscience Inc Earnings Call (Thomson Reuters StreetEvents) -10.12%
Mar-14-23 04:02PM	Yield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-08-23 08:32AM	Yield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023 (GlobeNewswire)
Mar-02-23 08:30AM	Yield10 Bioscience and American Airlines Sign MOU to Form a Collaboration to Develop the Value Chain for Camelina as a Feedstock Oil for Sustainable Aviation Fuel (GlobeNewswire) +8.21%
Feb-21-23 08:30AM	Yield10 Bioscience Announces Key Advancements in the Development of Herbicide Tolerant Camelina Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market (GlobeNewswire)
Feb-16-23 01:30PM	Yield10 Bioscience to Present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference on February 21, 2023 (ACCESSWIRE) +8.15%
Jan-11-23 04:01PM	Yield10 Bioscience and Mitsubishi Corporation Sign MOU to Evaluate the Establishment of a Partnership to Supply, Offtake and Market Camelina as a Feedstock Oil for Biofuel (GlobeNewswire) +12.61%
Dec-29-22 08:51AM	ADT and CarMax have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Dec-28-22 11:07AM	3 Under-$3 Consumer Staple Stocks Wall Street Analysts Recommend Buying (Zacks)
Nov-21-22 08:30AM	Yield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual Forum (GlobeNewswire)
Nov-17-22 06:20AM	Yield10 Bioscience Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-14-22 05:35PM	Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:02PM	Yield10 Bioscience Announces Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-10-22 08:30AM	Yield10 Bioscience Begins Winter 2022/2023 Field Test and Seed Production Program (GlobeNewswire) +5.86%
Nov-07-22 08:30AM	Yield10 Bioscience to Announce Third Quarter 2022 Financial Results and Host a Conference Call on Monday, November 14, 2022 (GlobeNewswire)
Oct-06-22 08:30AM	Yield10 Bioscience to Present at the MicroCap Rodeo Presents: Windy City Roundup 2022 on October 12 (ACCESSWIRE)
Oct-05-22 08:30AM	Yield10 Bioscience Appoints Willie Loh, Ph.D., Former Cargill Executive, to the Board of Directors (GlobeNewswire)
Sep-27-22 09:05AM	60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago (ACCESSWIRE)
Sep-15-22 04:20PM	Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the ISBP 2022 Conference (GlobeNewswire) +10.23%
Sep-08-22 08:30AM	Yield10 Bioscience to Present at the 24th Annual H.C. Wainwright Global Investment Conference (GlobeNewswire)
Aug-10-22 05:15PM	Metabolix, Inc. (YTEN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:02PM	Yield10 Bioscience Announces Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-02-22 08:30AM	Yield10 Bioscience to Announce Second Quarter 2022 Financial Results and Host a Conference Call on Wednesday, August 10, 2022 (GlobeNewswire)
Jul-12-22 09:05AM	Yield10 Bioscience Changes the Name of its Canadian Subsidiary to Yield10 Oilseeds Inc. (GlobeNewswire) +5.02%
Jun-15-22 08:56AM	Zacks Industry Outlook Highlights Archer Daniels Midland, Corteva, Yield10 Bioscience, Adecoagro and Calavo Grower (Zacks)
08:30AM	Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the CROPS 2022: Improving Agriculture Through Genomics Conference (GlobeNewswire)
May-19-22 08:30AM	Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference (GlobeNewswire) +7.19%
May-11-22 05:15PM	Metabolix, Inc. (YTEN) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -8.68%
04:02PM	Yield10 Bioscience Announces First Quarter 2022 Financial Results (GlobeNewswire)
May-03-22 08:30AM	Yield10 Bioscience to Announce First Quarter 2022 Financial Results and Host a Conference Call on Wednesday, May 11, 2022 (GlobeNewswire)
Apr-27-22 09:15AM	Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill Executive, as Special Commercial and Technical Advisor (GlobeNewswire)
Apr-08-22 07:25PM	Should You Buy Wheat Stocks? 3 Companies To Consider. (InvestorPlace)
Mar-28-22 10:23AM	10 GMO Stocks to Invest in Now (Insider Monkey)
Mar-22-22 08:30AM	Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat (GlobeNewswire)
Mar-16-22 08:30AM	Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference (GlobeNewswire) -9.89%
Mar-09-22 04:02PM	Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire) +6.93%
Mar-08-22 08:30AM	Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic (GlobeNewswire) -21.27%
Mar-03-22 08:30AM	Yield10 Bioscience Announces an Update on the Camelina Line E3902 Development Program for Producing Low-carbon Feedstock Oil for Renewable Diesel (GlobeNewswire) +8.03%
Mar-02-22 08:30AM	Yield10 Bioscience to Announce Fourth Quarter and Full Year 2021 Financial Results and Host a Conference Call on Wednesday, March 9, 2022 (GlobeNewswire)
Mar-01-22 08:30AM	Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola (GlobeNewswire)
Feb-02-22 08:30AM	Yield10 Bioscience Receives Favorable Ruling from the Argentine Biosafety Commission (CONABIA) for Companys Camelina Lines (GlobeNewswire)
Jan-25-22 08:30AM	Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations (GlobeNewswire) +7.16%
Jan-04-22 08:30AM	Yield10 Bioscience to Present at the H.C. Wainwright Bioconnect Virtual Conference (GlobeNewswire)
Dec-06-21 08:30AM	Yield10 Bioscience to Participate in the Benzinga Global Small Cap Conference on December 9, 2021 (GlobeNewswire) +5.91%
Dec-02-21 08:30AM	Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference (GlobeNewswire)
Nov-22-21 12:28PM	Will Yield10 Bioscience (NASDAQ:YTEN) Spend Its Cash Wisely? (Simply Wall St.)
Nov-10-21 05:15PM	Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:02PM	Yield10 Bioscience Announces Third Quarter 2021 Financial Results (GlobeNewswire)
Nov-04-21 03:01PM	Will Metabolix, Inc. (YTEN) Report Negative Q3 Earnings? What You Should Know (Zacks) +6.39%
Nov-03-21 08:30AM	Yield10 Bioscience to Announce Third Quarter 2021 Financial Results and Host a Conference Call on Wednesday, November 10, 2021 (GlobeNewswire)
Oct-07-21 08:30AM	Yield10 Bioscience to Participate in Maxim Group AgTech Virtual Conference (GlobeNewswire) +6.44%
Sep-09-21 08:30AM	Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (GlobeNewswire)
Aug-12-21 08:36AM	A Yield10 Bioscience, Inc. (NASDAQ:YTEN) insider increased their holdings by 93% last year (Simply Wall St.) -6.71%
Aug-11-21 05:45PM	Metabolix, Inc. (YTEN) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:02PM	Yield10 Bioscience Announces Second Quarter 2021 Financial Results (GlobeNewswire)
Aug-03-21 03:00PM	Will Metabolix, Inc. (YTEN) Report Negative Q2 Earnings? What You Should Know (Zacks)
08:30AM	Yield10 Bioscience to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Wednesday, August 11, 2021 (GlobeNewswire)
Aug-02-21 12:07PM	Yield10 Bioscience's Advanced Technology to Commercialize Omega-3 Nutritional Oils in Camelina (Benzinga)
Jul-13-21 08:30AM	Yield10 Bioscience Begins 2021 Field Test and Seed Scale Up Program (GlobeNewswire)
Jun-29-21 08:30AM	Yield10 Bioscience Announces Two New Hires as Camelina Business Plan Advances (GlobeNewswire) -9.38%
Jun-22-21 08:00AM	Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients (PR Newswire)
Jun-16-21 08:30AM	Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances Using Camelina Platform to Produce PHA Bioplastic at 2021 Synthetic Biology: Engineering, Evolution and Design Virtual Conference (GlobeNewswire) +5.90%
May-27-21 08:30AM	Yield10 Bioscience to Present at the LD Virtual Invitational XI on June 9, 2021 (GlobeNewswire)
May-12-21 10:21AM	Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) -6.82%

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHULER JACK W	10% Owner	Dec 19 '23	Sale	0.21	36,000	7,430	1,566,956	Dec 20 11:13 AM
SCHULER JACK W	10% Owner	Dec 08 '23	Sale	0.24	35,000	8,320	1,602,956	Dec 11 12:49 PM
SCHULER JACK W	10% Owner	Oct 06 '23	Sale	0.30	37,931	11,448	872,956	Oct 06 08:04 PM
SCHULER JACK W	10% Owner	Oct 05 '23	Sale	0.30	10,670	3,216	910,887	Oct 06 08:04 PM
SCHULER JACK W	10% Owner	Oct 04 '23	Sale	0.31	41,399	12,867	921,557	Oct 06 08:04 PM
SCHULER JACK W	10% Owner	Aug 15 '23	Buy	0.65	765,000	497,250	1,637,956	Oct 10 04:41 PM
SCHULER JACK W	10% Owner	May 05 '23	Buy	2.98	335,570	999,999	962,956	May 09 08:11 AM

Open in Screener

BDSX

Biodesix Inc

Apr 26 • 04:00PM ET

1.24

Dollar change -0.02
Percentage change -1.98	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VXF VTI IWC

Index	-	P/E	-	EPS (ttm)	-0.65	Insider Own	69.90%	Shs Outstand	96.24M	Perf Week	-1.20%
Market Cap	141.47M	Forward P/E	-	EPS next Y	-0.30	Insider Trans	-0.14%	Shs Float	34.48M	Perf Month	-14.24%
Income	-52.15M	PEG	-	EPS next Q	-0.15	Inst Own	11.14%	Short Float	0.91%	Perf Quarter	-37.31%
Sales	49.09M	P/S	2.88	EPS this Y	37.50%	Inst Trans	16.31%	Short Ratio	2.29	Perf Half Y	-18.21%
Book/sh	0.05	P/B	25.95	EPS next Y	23.75%	ROA	-54.32%	Short Interest	0.32M	Perf Year	-31.39%
Cash/sh	0.23	P/C	5.36	EPS next 5Y	-	ROE	-414.09%	52W Range	1.03 - 2.21	Perf YTD	-32.88%
Dividend Est.	-	P/FCF	-	EPS past 5Y	8.42%	ROI	-80.26%	52W High	-44.12%	Beta	1.13
Dividend TTM	-	Quick Ratio	1.15	Sales past 5Y	24.79%	Gross Margin	73.50%	52W Low	19.90%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	1.19	EPS Y/Y TTM	59.45%	Oper. Margin	-84.13%	RSI (14)	37.24	Volatility	3.16% 6.38%
Employees	217	Debt/Eq	13.25	Sales Y/Y TTM	28.46%	Profit Margin	-106.23%	Recom	1.00	Target Price	3.50
Option/Short	Yes / Yes	LT Debt/Eq	13.19	EPS Q/Q	71.86%	Payout	-	Rel Volume	0.10	Prev Close	1.26
Sales Surprise	-6.07%	EPS Surprise	8.34%	Sales Q/Q	52.66%	Earnings	May 08 AMC	Avg Volume	137.68K	Price	1.24
SMA20	-6.90%	SMA50	-13.02%	SMA200	-19.97%	Trades		Volume	13,931	Change	-1.98%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$21 → $11
Nov-23-20	Initiated	William Blair	Outperform
Nov-23-20	Initiated	Morgan Stanley	Overweight	$20
Nov-23-20	Initiated	Canaccord Genuity	Buy	$26
Nov-23-20	Initiated	BTIG Research	Buy	$22

Apr-24-24 06:00AM	Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 (Business Wire)
Apr-09-24 05:00PM	Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting (Business Wire) -9.93%
Apr-05-24 07:17AM	Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement (Business Wire) -7.28%
Mar-25-24 06:00AM	Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center (Business Wire)
Mar-04-24 09:04AM	Biodesix, Inc. (NASDAQ:BDSX) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:40PM	Loading…
Mar-01-24 10:40PM	Q4 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
06:31AM	Biodesix Inc (BDSX) Reports Strong Growth in Lung Diagnostic Test Volume and Gross Profit Margin (GuruFocus.com)
06:00AM	Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights (Business Wire)
Feb-26-24 06:00AM	Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference (Business Wire)
Feb-16-24 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 (Business Wire) -5.73%
Feb-13-24 03:00AM	Biodesix Inc CEO Scott Hutton Sells 64,390 Shares (GuruFocus.com)
Jan-26-24 09:04AM	3 Penny Stocks to Turn $999 Into $1 Million: January 2024 (InvestorPlace)
Nov-14-23 06:00AM	Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method (Business Wire)
Nov-09-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in November (Business Wire) -6.39%
Nov-07-23 04:01PM	Biodesix Announces Third Quarter 2023 Results and Highlights (Business Wire)
06:00AM	Loading…
Oct-24-23 06:00AM	Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023 (Business Wire) -5.00%
Oct-03-23 06:00AM	Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting (Business Wire)
Sep-07-23 06:00AM	Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer (Business Wire)
Sep-05-23 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in September (Business Wire) -11.76%
Aug-22-23 06:00AM	Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer (Business Wire)
Aug-09-23 10:25AM	Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript (Insider Monkey) -15.62%
Aug-08-23 08:38AM	Q2 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 05:15PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Second Quarter 2023 Results and Highlights (Business Wire)
Aug-01-23 06:00AM	Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference (Business Wire) +20.17%
Jul-26-23 07:58AM	Biodesix (NASDAQ:BDSX) investors are sitting on a loss of 49% if they invested a year ago (Simply Wall St.)
Jul-24-23 06:00AM	Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023 (Business Wire)
Jul-12-23 06:00AM	Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules (Business Wire)
Jul-06-23 09:11AM	Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services (Business Wire)
Jun-27-23 06:00AM	Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier (Business Wire) -5.83%
06:00AM	Loading…
Jun-01-23 06:00AM	Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting (Business Wire)
May-31-23 06:00AM	Biodesix to Participate in William Blairs 43rd Annual Growth Stock Conference (Business Wire)
May-28-23 08:09AM	Jack Schuler Spends US$65k On Biodesix Stock \ (Simply Wall St.)
May-25-23 06:00AM	Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing (Business Wire) +5.30%
May-24-23 06:00AM	Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors (Business Wire) +12.68%
May-18-23 07:00AM	Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference (Business Wire) -5.79%
May-12-23 11:10AM	Q1 2023 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents) -12.28%
May-11-23 05:25PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2023 Results and Highlights (Business Wire)
May-09-23 06:15PM	Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-27-23 06:00AM	Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023 (Business Wire)
Apr-12-23 06:53AM	Insiders of Biodesix, Inc. (NASDAQ:BDSX) must be frustrated after market cap dropped US$16m since recent purchases (Simply Wall St.)
Mar-15-23 09:31AM	Bullish Biodesix, Inc. (NASDAQ:BDSX) insiders filled their treasuries with US$34m worth of stock over last year (Simply Wall St.) +15.24%
Mar-08-23 07:14AM	Biodesix, Inc. (NASDAQ:BDSX) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.06%
Mar-06-23 07:25AM	Biodesix, Inc. (BDSX) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -10.00%
06:00AM	Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights (Business Wire)
Feb-28-23 06:00AM	Biodesix to Participate at Cowens 43rd Annual Healthcare Conference (Business Wire)
Feb-21-23 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (Business Wire)
Feb-16-23 06:27AM	Even after rising 15% this past week, Biodesix (NASDAQ:BDSX) shareholders are still down 39% over the past year (Simply Wall St.) +5.72%
Dec-19-22 06:00AM	Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test (Business Wire) +5.88%
Dec-16-22 04:01PM	Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors (Business Wire)
Dec-12-22 06:00AM	Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine (Business Wire) +8.57%
Nov-21-22 04:01PM	Biodesix Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares (Business Wire) -7.14%
Nov-17-22 12:26AM	Biodesix Announces Pricing of $35.1 Million Upsized Public Offering of Common Stock (Business Wire) +23.48%
Nov-16-22 04:05PM	Biodesix Announces Proposed Public Offering of Common Stock (Business Wire) +8.49%
04:01PM	Biodesix Announces Senior Secured Financing Agreement with Perceptive Advisors for Up to $50 Million (Business Wire)
Nov-10-22 09:00AM	Biodesix Presents New Data from the INSIGHT Study at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (Business Wire)
Nov-09-22 05:33AM	Biodesix Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.) -6.42%
Nov-03-22 07:15AM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:00AM	Biodesix Announces Third Quarter 2022 Results and Highlights (Business Wire)
Oct-20-22 06:00AM	Biodesix to Report Third Quarter 2022 Financial Results on November 3, 2022 (Business Wire)
Oct-17-22 05:05PM	Boulder's Biodesix snags $20M contract, plans move to larger space in Louisville (American City Business Journals)
06:00AM	Biodesix Awarded U.S. Federal Supply Schedule Contract for Its Comprehensive Lung Cancer Diagnostic Testing Solutions (Business Wire)
Oct-12-22 06:00AM	Biodesix to Present Data at the CHEST 2022 Annual Meeting Demonstrating High Sensitivity of the Nodify XL2® Blood-Based Lung Nodule Test in Various Patient Populations, Including Individuals Participating in Lung Cancer Screening Programs (Business Wire) -7.09%
Oct-11-22 06:00AM	Biodesix Announces Preliminary Revenue for Third Quarter 2022 (Business Wire)
Sep-06-22 06:00AM	Biodesix to Participate in Two Upcoming Investor Conferences in September (Business Wire) -6.56%
Aug-09-22 06:00AM	Biodesix Named a Top 100 Healthcare Technology Company of 2022 (Business Wire) -13.62%
Aug-06-22 04:30AM	Biodesix, Inc. (BDSX) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-04-22 07:15AM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:00AM	Biodesix Announces Second Quarter 2022 Results and Highlights (Business Wire)
Aug-03-22 06:00AM	Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference (Business Wire) +5.34%
Jul-30-22 10:44AM	Biodesix, Inc. (NASDAQ:BDSX) insiders placed bullish bets worth US$21m in the last 12 months (Simply Wall St.)
Jul-20-22 06:00AM	Biodesix to Present Data at IASLC 2022 World Conference Demonstrating that the VeriStrat® Test is Predictive of Progression Free Survival and Overall Survival in Patients with Low or Negative PD-L1 Treated with Immune Checkpoint Inhibitors (Business Wire)
Jul-19-22 06:00AM	Biodesix to Report Second Quarter 2022 Financial Results on August 4, 2022 (Business Wire)
Jun-22-22 09:19AM	Sotera Health Company (SHC) Stock Jumps 6.5%: Will It Continue to Soar? (Zacks)
Jun-15-22 10:11AM	Investors in Biodesix (NASDAQ:BDSX) have unfortunately lost 90% over the last year (Simply Wall St.)
Jun-07-22 06:00AM	Biodesix Obtains Medicare Coverage for the Nodify CDT® Lung Nodule Test (Business Wire) +16.23%
Jun-03-22 06:00AM	Biodesix Announces Research Agreement with Top US Cancer Center (Business Wire)
Jun-01-22 06:00AM	Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference (Business Wire) -6.76%
May-17-22 06:00AM	Biodesix to Present at the H.C. Wainwright Global Investment Conference (Business Wire)
May-12-22 06:00AM	Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to be Presented at ATS 2022 International Conference (Business Wire) +6.29%
May-11-22 07:15AM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -15.41%
06:00AM	Biodesix Announces First Quarter 2022 Results and Highlights (Business Wire)
Apr-27-22 06:00AM	Biodesix to Report First Quarter 2022 Financial Results on May 11, 2022 (Business Wire)
Apr-12-22 08:58AM	BioMed Stocks On the Move: Nova Mentis, PolarityTE, Biodesix and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, New Drugs for Cancers, Glaucoma, and Autism, and Diagnostics. (GlobeNewswire) +21.38%
Apr-11-22 06:00AM	Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan (Business Wire) -5.36%
Mar-29-22 06:00AM	Biodesix Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer (Business Wire)
Mar-19-22 09:19AM	Analysts' Revenue Estimates For Biodesix, Inc. (NASDAQ:BDSX) Are Surging Higher (Simply Wall St.)
Mar-15-22 10:00AM	Here's Why Biodesix, Inc. (BDSX) Looks Ripe for Bottom Fishing (Zacks)
Mar-14-22 07:15AM	Biodesix, Inc. (BDSX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:00AM	Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights (Business Wire)
Mar-07-22 04:01PM	Biodesix Announces Common Stock Purchase Agreement for up to $50 Million with Lincoln Park Capital (Business Wire)
03:00PM	Analysts Estimate Biodesix, Inc. (BDSX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Mar-03-22 06:00AM	Biodesix Announces Impactful Clinical Data on the Primary Immune Response (PIR) Test at the IASLC 2022 Therapies of Lung Cancer Meeting (Business Wire) -5.39%
Mar-01-22 06:00AM	Biodesix to Present at Cowens 42nd Annual Healthcare Conference (Business Wire)
Feb-28-22 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2021 Financial Results on March 14, 2022 (Business Wire)
Feb-22-22 06:00AM	Biodesix CEO Scott Hutton Named to The Healthcare Technology Reports List of Top 25 Biotech CEOs in 2022 (Business Wire) -17.03%
Feb-14-22 06:00AM	Biodesix Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue (Unaudited) (Business Wire)
Feb-09-22 06:00AM	Biodesix to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire) -6.23%
Jan-21-22 09:38PM	Conestoga Capital Advisors, LLC Buys Paycor HCM Inc, Definitive Healthcare Corp, Q2 Holdings ... (GuruFocus.com) -10.14%

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Boulder, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hutton Scott	President & CEO	Feb 12 '24	Sale	1.66	29,708	49,455	465,011	Feb 12 09:45 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 12 '24	Sale	1.66	8,699	14,481	169,410	Feb 12 09:44 PM
O'Kane Kieran	Chief Commercial Officer	Feb 12 '24	Sale	1.66	5,412	9,009	68,005	Feb 12 09:45 PM
Pestano Gary Anthony	Chief Development Officer	Feb 12 '24	Sale	1.66	5,022	8,360	123,250	Feb 12 09:45 PM
Vazquez Chris	Chief Accounting Officer	Feb 12 '24	Sale	1.66	922	1,535	9,548	Feb 12 09:46 PM
Hutton Scott	President & CEO	Feb 09 '24	Sale	1.92	34,682	66,472	494,719	Feb 12 09:45 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 09 '24	Sale	1.92	10,156	19,465	178,109	Feb 12 09:44 PM
O'Kane Kieran	Chief Commercial Officer	Feb 09 '24	Sale	1.92	6,319	12,111	73,417	Feb 12 09:45 PM
Pestano Gary Anthony	Chief Development Officer	Feb 09 '24	Sale	1.92	5,862	11,235	128,272	Feb 12 09:45 PM
Vazquez Chris	Chief Accounting Officer	Feb 09 '24	Sale	1.92	1,077	2,064	10,470	Feb 12 09:46 PM
Hutton Scott	President & CEO	Nov 10 '23	Sale	1.23	1,883	2,308	329,428	Nov 13 04:50 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 10 '23	Sale	1.23	491	602	136,573	Nov 13 04:50 PM
O'Kane Kieran	Chief Commercial Officer	Nov 10 '23	Sale	1.23	235	288	47,712	Nov 13 04:50 PM
Pestano Gary Anthony	Chief Development Officer	Nov 10 '23	Sale	1.23	218	267	104,501	Nov 13 04:51 PM
Vazquez Chris	Chief Accounting Officer	Nov 10 '23	Sale	1.23	108	132	6,251	Nov 13 04:51 PM
Hutton Scott	President & CEO	Nov 09 '23	Sale	1.27	1,882	2,391	331,311	Nov 13 04:50 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 09 '23	Sale	1.27	491	624	137,064	Nov 13 04:50 PM
O'Kane Kieran	Chief Commercial Officer	Nov 09 '23	Sale	1.27	234	297	47,947	Nov 13 04:50 PM
Pestano Gary Anthony	Chief Development Officer	Nov 09 '23	Sale	1.27	217	276	104,719	Nov 13 04:51 PM
Vazquez Chris	Chief Accounting Officer	Nov 09 '23	Sale	1.27	107	136	6,359	Nov 13 04:51 PM
SCHULER JACK W	Director	Aug 23 '23	Buy	1.71	87,500	149,240	30,707,722	Aug 23 06:56 PM
SCHULER JACK W	Director	Aug 22 '23	Buy	1.67	8,307	13,859	30,620,222	Aug 23 06:56 PM
SCHULER JACK W	Director	Aug 21 '23	Buy	1.64	32,556	53,411	30,611,915	Aug 23 06:56 PM
Hutton Scott	President & CEO	Aug 10 '23	Sale	1.27	6,889	8,728	318,013	Aug 10 07:28 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Aug 10 '23	Sale	1.27	1,788	2,265	131,535	Aug 10 07:27 PM
O'Kane Kieran	Chief Commercial Officer	Aug 10 '23	Sale	1.27	849	1,076	46,692	Aug 10 07:28 PM
Pestano Gary Anthony	Chief Development Officer	Aug 10 '23	Sale	1.27	786	996	103,558	Aug 10 07:29 PM
Vazquez Chris	Chief Accounting Officer	Aug 10 '23	Sale	1.27	279	353	5,865	Aug 10 07:30 PM
Hutton Scott	President & CEO	Aug 09 '23	Sale	1.39	6,893	9,570	324,902	Aug 10 07:28 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Aug 09 '23	Sale	1.39	1,789	2,484	133,323	Aug 10 07:27 PM
O'Kane Kieran	Chief Commercial Officer	Aug 09 '23	Sale	1.39	850	1,180	47,541	Aug 10 07:28 PM
Pestano Gary Anthony	Chief Development Officer	Aug 09 '23	Sale	1.39	787	1,093	104,344	Aug 10 07:29 PM
Vazquez Chris	Chief Accounting Officer	Aug 09 '23	Sale	1.39	280	389	6,144	Aug 10 07:30 PM
SCHULER JACK W	Director	May 31 '23	Buy	1.35	14,792	20,006	20,589,853	Jun 01 03:00 PM
SCHULER JACK W	Director	May 30 '23	Buy	1.36	11,849	16,150	20,575,061	Jun 01 03:00 PM
SCHULER JACK W	Director	May 25 '23	Buy	1.36	52,508	71,280	20,563,212	May 30 03:03 PM
SCHULER JACK W	Director	May 24 '23	Buy	1.25	35,308	43,980	20,510,704	May 26 03:00 PM
SCHULER JACK W	Director	May 23 '23	Buy	1.15	56,782	65,066	20,475,396	May 25 03:00 PM
SCHULER JACK W	Director	May 22 '23	Buy	1.11	29,425	32,529	20,418,614	May 24 03:47 PM
Hutton Scott	President & CEO	May 10 '23	Sale	1.58	3,848	6,065	240,722	May 10 08:16 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 10 '23	Sale	1.58	973	1,534	117,365	May 10 08:16 PM
Siurek Ryan H	Chief Accounting Officer	May 10 '23	Sale	1.58	564	889	40,268	May 10 08:16 PM
O'Kane Kieran	Chief Commercial Officer	May 10 '23	Sale	1.58	474	747	36,757	May 10 08:16 PM
Pestano Gary Anthony	Chief Development Officer	May 10 '23	Sale	1.58	426	671	99,460	May 10 08:16 PM
Hutton Scott	President & CEO	May 09 '23	Sale	1.57	9,934	15,561	244,570	May 10 08:16 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	May 09 '23	Sale	1.57	2,512	3,935	118,338	May 10 08:16 PM
Siurek Ryan H	Chief Accounting Officer	May 09 '23	Sale	1.57	1,456	2,281	40,832	May 10 08:16 PM
O'Kane Kieran	Chief Commercial Officer	May 09 '23	Sale	1.57	1,223	1,916	37,231	May 10 08:16 PM
Pestano Gary Anthony	Chief Development Officer	May 09 '23	Sale	1.57	1,101	1,725	99,886	May 10 08:16 PM

Open in Screener

AWH

Aspira Women's Health Inc

Apr 26 • 04:00PM ET

3.33

Dollar change +0.05
Percentage change 1.42	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

AWH Aspira Women's Health Inc daily Stock Chart

Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-1.78	Insider Own	45.51%	Shs Outstand	10.65M	Perf Week	-4.68%
Market Cap	41.05M	Forward P/E	-	EPS next Y	-0.86	Insider Trans	0.07%	Shs Float	6.73M	Perf Month	-3.01%
Income	-16.18M	PEG	-	EPS next Q	-0.34	Inst Own	5.79%	Short Float	2.52%	Perf Quarter	-37.12%
Sales	9.15M	P/S	4.49	EPS this Y	28.27%	Inst Trans	60.31%	Short Ratio	6.79	Perf Half Y	-33.33%
Book/sh	-0.22	P/B	-	EPS next Y	34.08%	ROA	-136.91%	Short Interest	0.17M	Perf Year	-30.70%
Cash/sh	0.21	P/C	15.79	EPS next 5Y	-	ROE	-701.30%	52W Range	2.31 - 6.75	Perf YTD	-18.47%
Dividend Est.	-	P/FCF	-	EPS past 5Y	5.77%	ROI	-	52W High	-50.72%	Beta	1.57
Dividend TTM	-	Quick Ratio	0.99	Sales past 5Y	25.92%	Gross Margin	57.54%	52W Low	44.09%	ATR (14)	0.26
Dividend Ex-Date	Dec 16, 2016	Current Ratio	1.03	EPS Y/Y TTM	89.53%	Oper. Margin	-200.36%	RSI (14)	46.99	Volatility	4.38% 9.67%
Employees	64	Debt/Eq	-	Sales Y/Y TTM	11.85%	Profit Margin	-176.74%	Recom	2.33	Target Price	5.25
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	97.90%	Payout	-	Rel Volume	0.68	Prev Close	3.28
Sales Surprise	-15.91%	EPS Surprise	32.75%	Sales Q/Q	-1.07%	Earnings	Mar 28 BMO	Avg Volume	24.94K	Price	3.33
SMA20	4.45%	SMA50	-8.80%	SMA200	-16.78%	Trades		Volume	16,905	Change	1.42%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-12-22	Resumed	Cantor Fitzgerald	Overweight	$4
Mar-29-21	Initiated	Truist	Buy	$12
Jan-29-21	Initiated	Cantor Fitzgerald	Overweight	$10
Oct-30-20	Initiated	William Blair	Outperform

Apr-09-24 08:00AM	Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California (GlobeNewswire) +9.93%
Apr-01-24 11:24AM	Aspira Women's Health Inc. (NASDAQ:AWH) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-28-24 11:53AM	AWH Stock Earnings: Aspira Womens Health Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -9.62%
07:30AM	Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-25-24 08:00AM	Aspira Women's Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call (GlobeNewswire)
08:00AM	Loading…
Mar-21-24 08:00AM	Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference (GlobeNewswire)
Mar-18-24 08:00AM	Aspira Women's Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President (GlobeNewswire)
Mar-11-24 08:00AM	Aspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024 (GlobeNewswire)
Feb-22-24 08:30AM	Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference (GlobeNewswire) -5.36%
Feb-12-24 08:00AM	Aspira Womens Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI) (GlobeNewswire)
Feb-06-24 08:00AM	Aspira Women's Health Announces OvaSuite(SM) Distribution Agreement in the Philippines (GlobeNewswire)
Jan-25-24 08:00AM	Aspira Women's Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
07:30AM	OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape (GlobeNewswire)
Dec-19-23 08:00AM	Aspira Women's Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024 (GlobeNewswire)
Dec-14-23 08:00AM	Aspira Women's Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024 (GlobeNewswire)
09:46AM	Loading…
Dec-08-23 09:46AM	New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT (GlobeNewswire)
Dec-07-23 09:20AM	New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT (GlobeNewswire) +12.84%
Dec-06-23 08:00AM	Aspira Women's Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis (GlobeNewswire)
Nov-28-23 08:00AM	Aspira Women's Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal) (GlobeNewswire)
Nov-27-23 09:47AM	Aspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS) (GlobeNewswire)
Nov-13-23 04:05PM	Aspira Women's Health Reports Third Quarter 2023 Financial Results (GlobeNewswire) -8.82%
Nov-09-23 08:00AM	Aspira Women's Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatch (GlobeNewswire)
Oct-31-23 08:00AM	Aspira Womens Health to Announce Third Quarter Earnings Results and Host a Conference Call on Monday, November 13, 2023 (GlobeNewswire)
Oct-25-23 08:00AM	Aspira Women's Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer Research (GlobeNewswire) -7.08%
Oct-23-23 08:00AM	Aspira Women's Health Establishes a New Clinical Advisory Board (GlobeNewswire) -8.12%
Oct-20-23 10:43AM	New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT (GlobeNewswire)
Sep-29-23 08:00AM	Aspira Women's Health to Present at the BioVenture Nexus Conference (GlobeNewswire)
Sep-13-23 08:00AM	Aspira Womens Health Regains Nasdaq Compliance (GlobeNewswire) +23.34%
Sep-11-23 08:00AM	Aspira Womens Health Announces Dr. Jody Berry as New Chief Scientific Officer (GlobeNewswire)
Aug-31-23 08:00AM	Aspira Womens Health Signs Exclusive Sample Procurement Agreement with The University of Oxford (GlobeNewswire) +14.57%
08:00AM	Loading…
Aug-29-23 08:00AM	Aspira Womens Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-28-23 08:00AM	Aspira Womens Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations (GlobeNewswire) +6.98%
Aug-14-23 04:01PM	Aspira Womens Health® Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-09-23 04:05PM	Aspira Womens Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer (GlobeNewswire)
Jul-31-23 08:00AM	Aspira Womens Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023 (GlobeNewswire)
Jul-20-23 08:30AM	Aspira Womens Health Announces $4.7 Million Registered Direct Offering (GlobeNewswire) -30.90%
Jun-28-23 08:00AM	Aspira Womens Health, Inc. Received a $1 MM Loan Forgiveness and 6-Month Payment Deferral from the CT DECD (GlobeNewswire) +8.33%
Jun-12-23 06:23PM	New to The Street Announces Five Corporate Interviews on its 478th Show, Airing on the Fox Business Network, Tonight, Monday, June 12, 2023, at 10:30 PM PT (GlobeNewswire)
Jun-08-23 01:23PM	New to The Street TV Announces its Four Business Guest Interviews, Episode 476 Airs on Bloomberg TV as A Sponsored Program, Tonight, Thursday, June 8, 2023, at 9:30 PM PT (GlobeNewswire)
01:23PM	New to The Street TV Announces its Five Business Guest Interviews, Episode 476 Airs on Bloomberg TV as A Sponsored Program, Tonight, Thursday, June 8, 2023, at 9:30 PM PT (GlobeNewswire)
Jun-05-23 08:00AM	Aspira Womens Health Appoints Dr. Winfred Parnell to its Board of Directors (GlobeNewswire)
Jun-02-23 09:35AM	New to The Street Announces its Corporate Guests TV Interviews, Airing as Episodes 474 and 475 with Shows Starting on Saturday, June 3, 2023, at 3:30 PM ET (GlobeNewswire)
08:00AM	Aspira Womens Health Regained Compliance with Nasdaqs Minimum Bid Price Requirement (GlobeNewswire)
May-31-23 08:00AM	Aspira Womens Health Announces the Publication of Three Abstracts by the American Society of Clinical Oncology (ASCO) Supporting the Clinical Utility of OvaSuite(SM) Ovarian Cancer Risk Assessment Tests (GlobeNewswire)
May-30-23 08:00AM	Aspira Womens Health to Participate at William Blairs 43rd Annual Growth Stock Conference (GlobeNewswire) -6.00%
May-26-23 09:15AM	New to The Street Announces the Televised Lineups for Shows 471, 472, and 473; Airings on Three Networks Will Begin on Saturday, May 27, 2023, at 3:30 PM ET (GlobeNewswire) -6.42%
May-19-23 09:38AM	New to The Street Announces its Televised Corporate Interviews Airing on Newsmax and The FOX Business Network, Episodes 469 and 470; Broadcastings Begin Saturday, May 20, 2023, at 3:30 PM ET (GlobeNewswire)
08:00AM	Aspira Womens Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference (GlobeNewswire)
May-16-23 04:05PM	Aspira Womens Health Names Torsten Hombeck as Chief Financial Officer (GlobeNewswire)
May-15-23 04:05PM	Aspira Womens Health to Host Investor Day on OvaWatch(SM) and EndoCheck Market Opportunities on May 23, 2023 (GlobeNewswire) +15.88%
09:00AM	Aspira Womens Health launches its New to The Street Media Series on May 8, 2023, World Ovarian Cancer Day (GlobeNewswire)
May-11-23 04:01PM	Aspira Womens Health® Reports First Quarter 2023 Financial Results (GlobeNewswire) -13.87%
12:33PM	Aspira Womens Health Announces 1-for-15 Reverse Stock Split (GlobeNewswire)
09:45AM	New to The Street Announces the Televised Lineups for Shows 466, 467, and 468; Airings on Three Networks, Starting Thursday, May 11, 2023, at 10:30 PM PT (GlobeNewswire)
08:00AM	Aspira Womens Health Signs an Exclusive Licensing Agreement with Dana Farber Cancer Institute for the Development of microRNA-based Ovarian Cancer Test (GlobeNewswire)
May-09-23 04:07PM	Aspira Womens Health Appoints Three New Members to its Board of Directors (GlobeNewswire)
Apr-27-23 04:05PM	Aspira Womens Health Announces Preliminary First Quarter 2023 OvaSuite Volume Increase of 29% and Plans to Announce Full Earnings Results on May 11, 2023 (GlobeNewswire)
Mar-27-23 07:12AM	Aspira Womens Health Inc. (NASDAQ:AWH) Q4 2022 Earnings Call Transcript (Insider Monkey) -11.70%
Mar-22-23 04:05PM	Aspira Womens Health Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-03-23 08:38AM	Aspira Womens Health to Announce Year End 2022 Financial Results and Host Conference Call on March 22, 2023 (GlobeNewswire) +19.14%
08:00AM	Aspira Womens Health Announces National Payer Coverage for OvaWatch (GlobeNewswire)
Jan-09-23 04:05PM	Aspira Womens Health Announces Preliminary Fourth Quarter 2022 Volume, Preliminary Results in Line with Cash Utilization Guidance, and Other Highlights (GlobeNewswire)
Jan-06-23 08:00AM	Aspira Womens Health Announces Publication of Real-World Data Validating Use of OvaWatch for the Management of Adnexal Masses (GlobeNewswire) +14.23%
Dec-27-22 08:00AM	Aspira Womens Health Announces Three Reimbursement Milestones that Improve Patient Access to its OvaSuite SM Testing Portfolio (GlobeNewswire)
Nov-29-22 04:01PM	Aspira Womens Health Announces the Commercial Launch of OvaWatch(SM) (GlobeNewswire)
Nov-10-22 07:00AM	Aspira Womens Health Reports Third Quarter 2022 Financial Results (GlobeNewswire) +6.23%
Nov-01-22 08:00AM	Aspira Womens Health to Announce Third Quarter 2022 Financial Results and Host Conference Call on Thursday, November 10 (GlobeNewswire)
Oct-06-22 04:05PM	Aspira Womens Health to Participate at the Upcoming MicroCap Rodeo Windy City Roundup 2022 (GlobeNewswire) -11.85%
Oct-05-22 08:00AM	Aspira Womens Health Announces Formal Launch of Co-Marketing and Distribution Collaboration with BioReference (GlobeNewswire)
Sep-27-22 09:05AM	60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago (ACCESSWIRE)
Sep-12-22 04:28PM	Aspira Womens Health Announces Publication of its Second-Generation MultiVariate Index Assay, OVERA®, in the Detection of Cancer in Filipino Women (GlobeNewswire)
Aug-23-22 08:00AM	Aspira Womens Health Inc. Announces Pricing of $9.0 Million Public Offering (GlobeNewswire) -37.28%
Aug-22-22 04:02PM	Aspira Womens Health Inc. Announces Proposed Public Offering (GlobeNewswire) -5.92%
Aug-18-22 04:05PM	Aspira Womens Health Hosting Womens Health Webinar on Ovarian Cancer Risk Assessments Utilizing Multivariant Index Assay (GlobeNewswire)
Aug-10-22 07:30AM	Aspira Womens Health Reports Second Quarter 2022 Financial Results (GlobeNewswire) -9.35%
Aug-01-22 08:00AM	Aspira Womens Health to Announce Second Quarter 2022 Financial Results and Host Conference Call on Wednesday, August 10 (GlobeNewswire)
Jul-11-22 06:26AM	Aspira Women's Health (NASDAQ:AWH) adds US$31m to market cap in the past 7 days, though investors from a year ago are still down 81% (Simply Wall St.) -14.71%
Jun-23-22 04:05PM	Aspira Womens Health Announces Appointment of Two New Board Members (GlobeNewswire) -7.11%
Jun-16-22 04:01PM	Aspira Womens Health Announces Publication of Paper Validating OvaWatch Algorithm in the Detection of Ovarian Cancer (GlobeNewswire) -6.57%
May-18-22 07:31AM	Does Aspira Women's Health (NASDAQ:AWH) Have A Healthy Balance Sheet? (Simply Wall St.)
May-16-22 01:20PM	36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 (ACCESSWIRE) +28.57%
May-12-22 04:01PM	Aspira Womens Health to Participate in the Upcoming Investor Conferences (GlobeNewswire)
May-11-22 07:30AM	Aspira Womens Health Reports First Quarter 2022 Financial Results (GlobeNewswire) -32.36%
Apr-29-22 08:00AM	Aspira Womens Health to Announce First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 11 (GlobeNewswire) -9.41%
Apr-02-22 01:40PM	What Kind Of Shareholders Hold The Majority In Aspira Women's Health Inc.'s (NASDAQ:AWH) Shares? (Simply Wall St.)
Mar-23-22 07:00AM	Aspira Womens Health Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire) -9.42%
Mar-15-22 08:00AM	Aspira Womens Health to Announce Year End 2021 Financial Results and Host Conference Call on Wednesday, March 23 (GlobeNewswire)
Feb-28-22 08:14AM	Aspira Womens Health Announces Appointment of Celeste Fralick, Ph.D., to its Board of Directors (GlobeNewswire) -5.22%
Feb-24-22 04:01PM	Valerie Palmieri Elevated to Executive Chair of the Board; Nicole Sandford Appointed President and CEO (GlobeNewswire) +9.00%
Feb-22-22 04:05PM	Aspira Womens Health, Inc. Expands Senior Leadership Team with Addition of Mr. Michael Newton as Head of Sales and Marketing (GlobeNewswire)
Feb-08-22 01:46PM	Aspira Womens Health to Participate in the Upcoming Winter Wonderland Best Ideas Conference (GlobeNewswire)
Feb-01-22 04:19AM	Aspira Women's Health (NASDAQ:AWH) shareholders have endured a 86% loss from investing in the stock a year ago (Simply Wall St.)
Jan-31-22 04:05PM	Aspira Womens Health Announces the Addition of 465,000 Covered Lives Through Medicaid Credentialing (GlobeNewswire) +12.04%
Jan-28-22 10:07AM	36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022 (ACCESSWIRE)
Jan-05-22 08:00AM	Aspira Womens Health Executes an Agreement with Axia Womens Health to Launch Aspira Synergy Genetics Platform (GlobeNewswire) -6.43%
08:00AM	Aspira Womens Health Appoints Minh Merchant as General Counsel (GlobeNewswire)
08:00AM	Aspira Womens Health Announces Fourth Quarter Operational Metrics and Provides Updates on Its OvaWatch and EndoCheck Programs (GlobeNewswire)
Dec-03-21 04:57AM	Is Aspira Women's Health (NASDAQ:AWH) Using Debt In A Risky Way? (Simply Wall St.) -9.95%
Nov-10-21 08:00AM	Aspira Womens Health Reports Third Quarter 2021 Financial Results (GlobeNewswire) -15.64%
Nov-03-21 03:01PM	Earnings Preview: Aspira (AWH) Q3 Earnings Expected to Decline (Zacks)

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sandford Nicole	President & CEO	Dec 06 '23	Buy	3.36	5,000	16,800	58,703	Dec 06 05:21 PM
Merchant Minh Hoang	Secretary & General Counsel	Dec 06 '23	Sale	3.37	980	3,303	0	Dec 08 05:28 PM
Hombeck Torsten	Chief Financial Officer	Sep 08 '23	Buy	4.30	2,246	9,658	3,000	Sep 12 06:37 PM
SCHULER JACK W	10% Owner	Jul 24 '23	Buy	2.75	181,800	499,950	1,883,656	Jul 25 05:39 PM
Sandford Nicole	President & CEO	Jul 24 '23	Buy	3.98	12,563	50,001	134,665	Jul 25 05:16 PM
Herchuk Jannie Prestridge	Director	Jul 24 '23	Buy	3.98	8,794	35,000	23,833	Jul 24 06:49 PM
Parnell Winfred	Director	Jul 24 '23	Buy	3.98	6,281	24,998	31,513	Jul 25 05:03 PM
Cavanaugh Stefanie L.	Director	Jul 24 '23	Buy	3.98	6,281	24,998	34,904	Jul 25 05:20 PM
Jordan Veronica GH	Director	Jul 24 '23	Buy	3.98	3,769	15,001	34,575	Jul 24 06:58 PM
Vos Ellen O'Connor	Director	Jul 24 '23	Buy	3.98	3,769	15,001	32,878	Jul 26 04:28 PM
Merchant Minh Hoang	General counsel and secretary	Jul 24 '23	Buy	3.98	754	3,001	3,865	Jul 25 04:58 PM
Fralick Celeste Rachelle	Director	Jul 24 '23	Buy	3.98	754	3,001	12,032	Jul 26 07:28 PM
Hombeck Torsten	Chief Financial Officer	Jul 24 '23	Buy	3.98	754	3,001	754	Jul 24 06:53 PM
Phan Ryan Thinh	CSO & COO	Jul 24 '23	Buy	3.98	628	2,499	3,939	Jul 25 05:11 PM

Open in Screener

SLNO

Soleno Therapeutics Inc

Apr 26 • 04:00PM ET

37.89

Dollar change +0.55
Percentage change 1.47	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

SLNO Soleno Therapeutics Inc daily Stock Chart

Held by: VTI DWAS VXF LABU SBIO ITOT HRTS FHLC USVM ISCG

Index	-	P/E	-	EPS (ttm)	-2.98	Insider Own	39.22%	Shs Outstand	31.68M	Perf Week	1.04%
Market Cap	1.27B	Forward P/E	-	EPS next Y	-0.75	Insider Trans	-2.37%	Shs Float	20.31M	Perf Month	-11.58%
Income	-38.99M	PEG	-	EPS next Q	-0.37	Inst Own	58.30%	Short Float	15.28%	Perf Quarter	-18.69%
Sales	0.00M	P/S	-	EPS this Y	33.76%	Inst Trans	-0.96%	Short Ratio	10.00	Perf Half Y	57.88%
Book/sh	4.97	P/B	7.62	EPS next Y	51.81%	ROA	-37.64%	Short Interest	3.10M	Perf Year	988.79%
Cash/sh	5.08	P/C	7.46	EPS next 5Y	15.00%	ROE	-46.45%	52W Range	3.16 - 53.82	Perf YTD	-5.86%
Dividend Est.	-	P/FCF	-	EPS past 5Y	24.34%	ROI	-24.73%	52W High	-29.60%	Beta	-1.45
Dividend TTM	-	Quick Ratio	14.89	Sales past 5Y	0.00%	Gross Margin	-	52W Low	1099.05%	ATR (14)	1.94
Dividend Ex-Date	-	Current Ratio	14.89	EPS Y/Y TTM	8.51%	Oper. Margin	0.00%	RSI (14)	41.66	Volatility	4.46% 4.59%
Employees	42	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	64.33
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	43.56%	Payout	-	Rel Volume	0.45	Prev Close	37.34
Sales Surprise	-	EPS Surprise	-20.75%	Sales Q/Q	-	Earnings	Mar 06 AMC	Avg Volume	310.33K	Price	37.89
SMA20	-4.06%	SMA50	-12.61%	SMA200	34.05%	Trades		Volume	138,607	Change	1.47%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-05-24	Initiated	Piper Sandler	Overweight	$93
Jan-23-24	Initiated	Stifel	Buy	$63
Nov-21-23	Resumed	Guggenheim	Buy	$40
Sep-29-20	Initiated	Guggenheim	Buy	$8
Jan-10-20	Initiated	Craig Hallum	Buy	$8
Dec-23-19	Initiated	Oppenheimer	Outperform	$10
Feb-13-18	Reiterated	Maxim Group	Buy	$8 → $4

Apr-19-24 04:05PM	Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-04-24 01:54AM	CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO) (GuruFocus.com)
01:54AM	Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO) (GuruFocus.com)
Mar-08-24 04:05PM	Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-06-24 10:53PM	SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023 (InvestorPlace)
04:05PM	Loading…
04:05PM	Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Feb-22-24 08:00AM	Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-14-24 08:50AM	Soleno Therapeutics, Inc. (SLNO) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Feb-05-24 10:10AM	Charter downgraded, Cigna upgraded: Wall Street's top analyst calls (The Fly) +5.91%
Feb-01-24 08:00AM	Soleno Therapeutics to Present at Upcoming February Investor Conferences (GlobeNewswire)
Jan-29-24 04:05PM	Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-26-24 08:50AM	Here's Why Momentum in Soleno Therapeutics, Inc. (SLNO) Should Keep going (Zacks)
Jan-24-24 08:00AM	Soleno Therapeutics Strengthens Leadership Team with Key Appointments (GlobeNewswire)
Jan-10-24 08:50AM	Here's What Could Help Soleno Therapeutics, Inc. (SLNO) Maintain Its Recent Price Strength (Zacks)
Jan-05-24 08:00AM	Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
06:59PM	Loading…
Dec-21-23 06:59PM	Why Soleno Therapeutics Stock Ticked Higher on Thursday (Motley Fool)
Dec-15-23 09:30AM	Growth Stocks Under $50 for December 2023 (Investopedia)
Dec-14-23 03:44PM	Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023 (InvestorPlace)
03:05PM	Insider Sell Alert: CEO Bhatnagar Anish Unloads 93,408 Shares of Soleno Therapeutics Inc (SLNO) (GuruFocus.com)
07:00AM	3 Stock Winners That Are Up 500% or More in 2023 (InvestorPlace)
Dec-01-23 03:06AM	Insider Sell Alert: CFO James Mackaness Sells 8,081 Shares of Soleno Therapeutics Inc (SLNO) (GuruFocus.com)
Nov-27-23 01:02PM	Feeling Lucky? 5 Jackpot Stocks to Buy for 2024. (InvestorPlace)
Nov-20-23 03:06PM	3 Biotech Stocks With Big-Time Breakthrough Potential (InvestorPlace) +8.50%
Nov-10-23 04:05PM	Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-07-23 08:00AM	Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-06-23 08:00AM	Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open-Label Study of DCCR in Prader-Willi Syndrome (GlobeNewswire)
Nov-01-23 11:30AM	Top Stocks for November 2023 (Investopedia)
Oct-26-23 10:33AM	12 Best Performing NASDAQ Stocks in 2023 (Insider Monkey)
Oct-20-23 01:22PM	12 Best Performing Biotech Stocks in 2023 (Insider Monkey)
Oct-16-23 04:07PM	The Ten Most-Shorted Stocks Include Huge Market Movers In 2023 (Investor's Business Daily)
08:01AM	Loading…
08:01AM	The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA (Investor's Business Daily)
Oct-06-23 06:25PM	Xerox, Mastercraft Boat, and More Stocks See Action From Activist Investors (Barrons.com)
Oct-04-23 06:16PM	Correcting & Replacing -- Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium (GlobeNewswire)
04:05PM	Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium (GlobeNewswire)
Oct-03-23 08:00AM	Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505% (Investor's Business Daily)
Oct-02-23 04:05PM	Soleno Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -10.27%
Sep-28-23 09:58AM	Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data (Zacks) +33.48%
08:30AM	Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants (GlobeNewswire)
Sep-27-23 06:08PM	Daily Market Wrap Up: Micron Technology's Mixed Guidance, Morgan Stanley's Dividend Picks, and ... (GuruFocus.com) -22.87%
04:55PM	Why Shares of Soleno Therapeutics Dropped on Wednesday (Motley Fool)
04:01PM	Soleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants (GlobeNewswire)
03:30PM	Dont Miss the Boom: 3 ETFs Set to Explode Higher (InvestorPlace)
01:28PM	Soleno Therapeutics Stock Dives After Its Meteoric Rise on Positive Study Results (Barrons.com)
07:21AM	Soleno (SLNO) Soars as Prader-Willi Syndrome Study Meets Goal (Zacks)
Sep-26-23 04:11PM	Soleno Catapults 505% After Its Pill Controls Hunger In Obesity-Causing Genetic Disease (Investor's Business Daily) +504.97%
12:51PM	Why Shares of Soleno Therapeutics Are Booming on Tuesday (Motley Fool)
12:17PM	Soleno Catapults Almost 400% After Its Pill Controls Hunger In Obesity-Causing Genetic Disease (Investor's Business Daily)
07:30AM	Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome (GlobeNewswire)
Sep-25-23 08:00AM	Soleno Therapeutics to Present at the Cantor Global Healthcare Conference (GlobeNewswire)
Aug-18-23 09:02PM	Carlyle Group Inc. Acquires Stake in Soleno Therapeutics Inc. (GuruFocus.com)
Aug-16-23 08:00AM	Soleno Therapeutics Announces Appointment of Industry Veteran Matthew Pauls, J.D., M.B.A. to Board of Directors (GlobeNewswire)
Aug-08-23 04:05PM	Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results (GlobeNewswire) +5.77%
Jun-02-23 06:35PM	LL Flooring and Ingevity Stock See Action From Activist Investors (Barrons.com)
May-09-23 04:05PM	Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-03-23 04:05PM	Soleno Therapeutics Completes Enrollment in Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome (GlobeNewswire)
Apr-26-23 06:50AM	Here's Why We're A Bit Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation (Simply Wall St.) -5.95%
Mar-28-23 08:00AM	Soleno Therapeutics to Participate in the Guggenheim Healthcare Talks Genomic Medicines and Rare Disease Days (GlobeNewswire)
Mar-21-23 04:05PM	Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results (GlobeNewswire) +5.94%
Mar-16-23 06:33AM	Soleno Therapeutics, Inc.'s (NASDAQ:SLNO) Shift From Loss To Profit (Simply Wall St.)
Mar-07-23 08:00AM	Soleno Therapeutics to Participate in the Oppenheimer 33rd Annual Healthcare Conference (GlobeNewswire)
Feb-01-23 04:25PM	7 Top Short-Squeeze Candidates to Watch in February (InvestorPlace)
Jan-26-23 08:00AM	Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Previously Completed Phase 3 Trial of DCCR for Treatment of Prader-Willi Syndrome (GlobeNewswire) +7.47%
Jan-13-23 12:00PM	Soleno Therapeutics, Inc. (SLNO) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks) +8.18%
Dec-19-22 08:00AM	Soleno Therapeutics Announces Financing Commitment for up to $60 Million (GlobeNewswire) +103.86%
Nov-09-22 04:05PM	Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-10-22 11:23AM	Catalyst Pharmaceuticals (CPRX) Rallies 80.69% YTD: Here's Why (Zacks)
Oct-03-22 08:00AM	Soleno Therapeutics Announces Initiation of Randomized Withdrawal Study of DCCR for the Treatment of Prader-Willi Syndrome (GlobeNewswire)
Sep-30-22 11:47AM	Catalyst Pharma's (CPRX) sNDA for Firdapse Approved by the FDA (Zacks)
Sep-29-22 11:42AM	KemPharm (KMPH) Up On Positive Data From Sleep Disorder Study (Zacks) -5.23%
Sep-22-22 10:57AM	Feneca (FENC) Gets FDA Nod for Cancer-Related Hearing Loss Drug (Zacks) -8.08%
Sep-20-22 12:04PM	Aurinia's (AUPH) Oral Lupus Drug Lupkynis Gets European Approval (Zacks)
Sep-12-22 11:26AM	Spectrum Pharmaceuticals (SPPI) Gets Nod for Rolvedon Injection (Zacks) +5.05%
Sep-07-22 10:02AM	Ironwood's (IRWD) Functional Constipation Study in Kids Succeeds (Zacks)
Sep-06-22 08:00AM	Soleno Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-18-22 11:04AM	RedHill (RDHL) Up on Orphan Drug Tag for NTM Disease Drug (Zacks)
Aug-10-22 04:05PM	Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-20-22 10:59AM	Soleno Shares Surge On Regulatory Update For Its Prader-Willi Syndrome Hopeful (Benzinga) +5.89%
08:00AM	Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome (GlobeNewswire)
Jul-11-22 04:05PM	Soleno Therapeutics Announces Presentation of DCCR Data at the 11th International Prader-Willi Syndrome Organisation Conference (GlobeNewswire) -11.41%
Jul-07-22 09:36AM	Here's Why Assertio Holdings (ASRT) Stock is Up This Year (Zacks) +10.34%
08:39AM	Zacks Industry Outlook Highlights Chinook Therapeutics, Assertio Holdings, Viracta Therapeutics and Soleno Therapeutics (Zacks)
Jul-06-22 09:32AM	4 Small Stocks to Bet on in an Upbeat Drugs Industry (Zacks)
Jun-14-22 05:56AM	Why Soleno Therapeutics Shares Are Surging Today (Benzinga) +5.93%
Jun-13-22 04:05PM	Soleno Therapeutics Presents Long Term Data for DCCR Showing Metabolic and Body Composition Improvements in Patients with PWS (GlobeNewswire) -10.66%
Jun-07-22 08:00AM	Soleno Therapeutics Announces Presentations at ENDO 2022 (GlobeNewswire)
May-19-22 04:05PM	Soleno Therapeutics Announces Presentations at the 2022 European Congress of Endocrinology (GlobeNewswire)
May-17-22 11:53AM	KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M (Zacks) +7.64%
08:00AM	Soleno Therapeutics to Participate in the H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-12-22 10:20AM	Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug (Zacks) +6.11%
May-11-22 11:20AM	Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y (Zacks) -6.19%
May-10-22 04:01PM	Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-06-22 11:11AM	Corcept's (CORT) Q1 Earnings & Revenues Fall Shy of Estimates (Zacks) -5.50%
May-05-22 11:26AM	Pacira's (PCRX) Q1 Earnings Miss Estimates, Revenues Rise Y/Y (Zacks) -5.32%
11:07AM	Zoetis' (ZTS) Q1 Earnings and Revenues Surpass Estimates (Zacks)
May-02-22 04:05PM	Soleno Therapeutics Announces Presentation of Long-Term Hyperphagia and Behavioral Data in Patients Receiving DCCR for Treatment of Prader-Willi Syndrome (GlobeNewswire)
Apr-13-22 03:34PM	High school seniors saw a problem so they started a biotech company (American City Business Journals) +10.64%
Apr-11-22 06:16PM	How Covid stymied a Peninsula company's drug aimed at calming insatiable appetites (American City Business Journals) -6.69%
Apr-01-22 11:49AM	Soleno Therapeutics Announces Closing of Approximately $15 Million Underwritten Public Offering (GlobeNewswire) -5.78%
Mar-31-22 04:05PM	Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results (GlobeNewswire)
Mar-29-22 08:30AM	Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering (GlobeNewswire) -22.81%

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Anish Bhatnagar	CHIEF EXECUTIVE OFFICER	Apr 01 '24	Sale	41.34	18,980	784,645	152,790	Apr 03 09:36 PM
Mackaness James H	CHIEF FINANCIAL OFFICER	Apr 01 '24	Sale	41.34	5,175	213,937	62,953	Apr 03 09:39 PM
Yen Kristen	SEE REMARKS	Apr 01 '24	Sale	41.34	2,218	91,694	23,422	Apr 03 09:40 PM
Hirano Patricia C	SEE REMARKS	Apr 01 '24	Sale	41.34	2,218	91,694	41,812	Apr 03 09:37 PM
Anish Bhatnagar	CHIEF EXECUTIVE OFFICER	Jan 25 '24	Sale	48.30	2,527	122,054	171,770	Jan 29 05:42 PM
Hirano Patricia C	SEE REMARKS	Jan 25 '24	Sale	48.30	832	40,186	43,142	Jan 29 05:44 PM
Yen Kristen	SEE REMARKS	Jan 25 '24	Sale	48.30	397	19,175	25,640	Jan 29 05:47 PM
Hirano Patricia C	See Remarks	Dec 14 '23	Sale	36.49	1,359	49,584	19,974	Dec 15 06:00 PM
Yen Kristen	See Remarks	Dec 13 '23	Option Exercise	2.55	17,916	45,644	19,953	Dec 14 07:57 PM
Yen Kristen	See Remarks	Dec 13 '23	Sale	37.76	17,916	676,557	2,037	Dec 14 07:57 PM
Hirano Patricia C	See Remarks	Dec 13 '23	Sale	38.79	4,885	189,513	21,333	Dec 15 06:00 PM
Yen Kristen	See Remarks	Dec 12 '23	Sale	36.95	19,913	735,874	2,037	Dec 14 07:57 PM
Mackaness James H	Chief Financial Officer	Dec 11 '23	Option Exercise	2.60	15,000	38,925	44,610	Dec 13 09:34 PM
Anish Bhatnagar	Chief Executive Officer	Dec 11 '23	Sale	35.67	93,408	3,331,701	24,297	Dec 13 09:34 PM
Mackaness James H	Chief Financial Officer	Dec 11 '23	Sale	36.41	32,482	1,182,828	12,128	Dec 13 09:34 PM
Anish Bhatnagar	Chief Executive Officer	Nov 30 '23	Sale	28.65	27,716	794,116	108,062	Dec 04 08:02 PM
Mackaness James H	Chief Financial Officer	Nov 30 '23	Sale	28.65	4,186	119,937	21,303	Dec 04 08:04 PM
Yen Kristen	See Remarks	Nov 30 '23	Sale	28.65	3,963	113,547	21,950	Dec 04 08:06 PM
Hirano Patricia C	See Remarks	Nov 30 '23	Sale	28.65	3,823	109,536	26,218	Dec 04 08:03 PM
Anish Bhatnagar	Chief Executive Officer	Nov 29 '23	Sale	27.83	27,827	774,535	135,778	Nov 30 09:50 PM
Mackaness James H	Chief Financial Officer	Nov 29 '23	Sale	27.83	4,203	116,986	25,489	Nov 30 09:52 PM
Yen Kristen	See Remarks	Nov 29 '23	Sale	27.83	3,979	110,751	25,913	Nov 30 09:52 PM
Hirano Patricia C	See Remarks	Nov 29 '23	Sale	27.83	3,839	106,855	30,041	Nov 30 09:51 PM
Anish Bhatnagar	Chief Executive Officer	Nov 28 '23	Sale	27.12	25,678	696,514	163,605	Nov 30 09:50 PM
Mackaness James H	Chief Financial Officer	Nov 28 '23	Sale	27.12	3,878	105,190	29,692	Nov 30 09:52 PM
Yen Kristen	See Remarks	Nov 28 '23	Sale	27.12	3,671	99,575	29,892	Nov 30 09:52 PM
Hirano Patricia C	See Remarks	Nov 28 '23	Sale	27.12	3,542	96,076	33,880	Nov 30 09:51 PM
Anish Bhatnagar	Chief Executive Officer	Oct 20 '23	Option Exercise	3.16	9,643	30,500	198,926	Dec 13 09:32 PM
Mackaness James H	Chief Financial Officer	Oct 02 '23	Option Exercise	2.95	8,309	24,497	41,879	Dec 13 09:32 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Sep 28 '23	Buy	20.00	250,000	5,000,000	3,074,542	Sep 28 03:45 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Sep 26 '23	Buy	16.40	616,789	10,113,916	2,824,542	Sep 28 03:45 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Jun 06 '23	Buy	5.93	200	1,186	2,207,753	Jun 06 04:16 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Jun 05 '23	Buy	5.98	78,468	469,239	2,207,553	Jun 06 04:16 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Jun 02 '23	Buy	5.93	64,630	383,256	2,129,085	Jun 06 04:16 PM
PERCEPTIVE ADVISORS LLC	10% Owner	Jun 01 '23	Buy	5.59	7,500	41,925	2,064,455	Jun 01 05:41 PM
PERCEPTIVE ADVISORS LLC	10% Owner	May 31 '23	Buy	5.28	10,000	52,800	2,056,955	Jun 01 05:41 PM
PERCEPTIVE ADVISORS LLC	10% Owner	May 30 '23	Buy	5.34	17,500	93,450	2,046,955	Jun 01 05:41 PM
PERCEPTIVE ADVISORS LLC	10% Owner	May 26 '23	Buy	5.27	22,500	118,575	2,029,455	May 26 05:57 PM
PERCEPTIVE ADVISORS LLC	10% Owner	May 25 '23	Buy	5.18	37,500	194,250	2,006,955	May 26 05:57 PM
PERCEPTIVE ADVISORS LLC	10% Owner	May 24 '23	Buy	5.48	25,000	137,000	1,969,455	May 26 05:57 PM
PERCEPTIVE ADVISORS LLC	10% Owner	May 23 '23	Buy	5.45	27,500	149,875	1,944,455	May 23 06:47 PM
PERCEPTIVE ADVISORS LLC	10% Owner	May 22 '23	Buy	5.12	27,300	139,776	1,916,955	May 23 06:47 PM
PERCEPTIVE ADVISORS LLC	10% Owner	May 19 '23	Buy	4.62	25,200	116,424	1,889,655	May 23 06:47 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

YTEN

Yield10 Bioscience Inc

BDSX

Biodesix Inc

AWH

Aspira Women's Health Inc

SLNO

Soleno Therapeutics Inc

Upgrade your FINVIZ experience